|
View results for a demographic group: |
Select a different topic: |
| View results for a different geographical area: |
|
| Total Respond.^ |
No Use | Use single product | Use multiple products | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | ||
| TOTAL | 3,307 | 2,619 | 77.2 | 74.9-79.3 | 529 | 17.1 | 15.2-19.1 | 159 | 5.7 | 4.6- 7.1 |
| GENDER | ||||||||||
| Male | 1,394 | 1,001 | 69.5 | 65.8-73.0 | 291 | 23.2 | 19.9-26.8 | 102 | 7.3 | 5.7- 9.4 |
| Female | 1,913 | 1,618 | 83.8 | 81.2-86.1 | 238 | 11.8 | 10.0-14.0 | 57 | 4.4 | 3.0- 6.3 |
| Have Health Insurance | ||||||||||
| Yes | 3,017 | 2,406 | 77.3 | 74.9-79.6 | 478 | 17.2 | 15.2-19.4 | 133 | 5.4 | 4.3- 6.9 |
| No | 248 | 177 | 73.4 | 66.2-79.5 | 46 | 17.4 | 12.5-23.8 | 25 | 9.2 | 5.7-14.4 |
| Body Mass Index | ||||||||||
| Underweight | 59 | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Recommended Range | 786 | 616 | 76.2 | 71.6-80.4 | 131 | 18.3 | 14.5-22.7 | 39 | 5.5 | 3.6- 8.3 |
| Overweight | 1,070 | 850 | 75.9 | 71.4-79.9 | 169 | 17.6 | 14.0-21.7 | 51 | 6.6 | 4.5- 9.6 |
| Obese | 1,152 | 899 | 77.1 | 73.5-80.4 | 191 | 16.9 | 14.0-20.2 | 62 | 6.0 | 4.3- 8.3 |
| Current Smoker | ||||||||||
| Yes | 412 | *** | *** | *** | 285 | 66.2 | 58.8-72.9 | 127 | 33.8 | 27.1-41.2 |
| No | 2,870 | 2,600 | 89.6 | 87.9-91.0 | 239 | 9.2 | 7.8-10.8 | 31 | 1.3 | 0.8- 1.9 |
| History of CVD** | ||||||||||
| Yes | 384 | 283 | 74.2 | 66.9-80.3 | 81 | 21.1 | 15.3-28.4 | 20 | 4.7 | 2.8- 7.8 |
| No | 2,902 | 2,318 | 77.5 | 75.1-79.7 | 446 | 16.6 | 14.6-18.8 | 138 | 5.9 | 4.7- 7.3 |
| Binge Drinker | ||||||||||
| Yes | 350 | 188 | 52.0 | 44.8-59.1 | 101 | 30.3 | 24.0-37.4 | 61 | 17.7 | 13.3-23.3 |
| No | 2,794 | 2,294 | 80.5 | 78.1-82.8 | 408 | 15.2 | 13.3-17.5 | 92 | 4.2 | 3.1- 5.7 |
| Heavy Drinker | ||||||||||
| Yes | 148 | *** | *** | *** | *** | *** | *** | 25 | 17.9 | 11.2-27.2 |
| No | 2,998 | 2,410 | 78.6 | 76.3-80.8 | 463 | 16.2 | 14.2-18.3 | 125 | 5.2 | 4.0- 6.6 |
| COPD | ||||||||||
| Yes | 283 | 170 | 55.9 | 46.8-64.6 | 88 | 31.0 | 23.6-39.5 | *** | *** | *** |
| No | 3,014 | 2,441 | 79.0 | 76.7-81.1 | 439 | 15.9 | 14.0-18.0 | 134 | 5.1 | 4.1- 6.4 |
| Current Asthma | ||||||||||
| Yes | 361 | 285 | 79.1 | 72.8-84.2 | 61 | 17.3 | 12.5-23.3 | *** | *** | *** |
| No | 2,933 | 2,323 | 77.0 | 74.6-79.2 | 466 | 17.0 | 15.0-19.3 | 144 | 6.0 | 4.8- 7.4 |
| Diabetes | ||||||||||
| Yes | 496 | 407 | 78.8 | 71.7-84.4 | 77 | 19.4 | 13.8-26.4 | *** | *** | *** |
| No | 2,805 | 2,206 | 76.9 | 74.5-79.1 | 452 | 16.8 | 14.8-19.0 | 147 | 6.3 | 5.1- 7.9 |
| Functional Disability | ||||||||||
| Yes | 1,124 | 828 | 70.7 | 66.6-74.5 | 226 | 21.6 | 18.3-25.3 | 70 | 7.7 | 5.6-10.6 |
| No | 2,153 | 1,765 | 80.3 | 77.5-82.8 | 300 | 14.9 | 12.7-17.5 | 88 | 4.8 | 3.6- 6.4 |
| Has two or more chronic diseases† | ||||||||||
| Yes | 979 | 735 | 72.9 | 68.4-77.0 | 194 | 20.4 | 16.8-24.5 | 50 | 6.7 | 4.3-10.2 |
| No | 2,326 | 1,882 | 78.6 | 76.0-81.0 | 335 | 16.0 | 13.8-18.4 | 109 | 5.4 | 4.2- 6.9 |
*Current use of cigarettes, e-cigarettes, smokeless tobacco, cigars, or hookah.
This table only includes respondents who were asked the questions on other tobacco products.
**History of cardiovascular disease includes history of heart attack or coronary heart disease or stroke.
†Chronic diseases include heart disease (heart attack/stoke/angina), current asthma, skin cancer, other cancer, COPD, arthritis, depression, kidney disease and diabetes.
PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2023 are NOT comparable to 2010
and earlier years.
***The estimate was suppressed because it did not meet statistical reliability standards. See BRFSS 2023 Annual Results Technical Notes for more details.
^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.
BRFSS Home | Annual Questionnaires | Technical Notes
This page was generated on 07APR25.
FOLLOW US